Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Has the Quota of Signet Ring Cells an Influence on Prognosis and Treatment Strategy in the Upper GI Tract Adenocarcinomas?

NCT01249859 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT01249859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01249859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Has the Quota of Signet Ring Cells an Influence on Prognosis and Treatment Strategy in the Upper GI Tract Adenocarcinomas?
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Completed
Start date
March 31, 2010
Completion date
December 31, 2010
Enrollment
2,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

case-control study, oesophagus, prognostic, signet ring cell carcinoma, stomach disease